HomeTrading IdeasMarkets Today: Copper Saga...

Markets Today: Copper Saga Heats Up, More Tariffs and DAX Holds Firm Near All-Time

U.S. stock futures and the dollar slipped after President Donald Trump escalated trade tensions by announcing a 50% tariff on and sending new letters to raise tariffs on other countries.

Asian Market Wrap

dropped 0.3%, and the slipped 0.1% on Thursday. Treasuries and Asian stocks stayed steady, while held near its record high from Wednesday around the $112k mark.

Brazilian markets tumbled after Trump announced new tariffs, including a 50% tax on goods from Brazil. Copper prices rose after Trump confirmed a 50% tariff on copper imports starting August 1, impacting producers. Copper futures on the London Metal Exchange climbed 0.4% to $9,664.50 a ton, while U.S. Comex contracts jumped nearly 3%.

Global copper producers are rushing to ship supplies faster, redirecting deliveries to Hawaii and Puerto Rico to save time.

Highest Tariff Level Since 1934

After Trump announced higher tariffs on imports from 14 countries, Yale Budget Lab estimated the U.S. tariff rate has risen to 17.6%, the highest in 90 years, up from 15.8%.

The Trump administration claims these tariffs are a major source of revenue. Treasury Secretary Scott Bessent said the U.S. has collected $100 billion so far and could reach $300 billion by year-end, compared to the usual $80 billion annually.

Source: LSEG

European Open as Earnings Season Approaches

European stocks rose on Thursday, led by mining shares, as hopes grew for a U.S.-EU trade deal. The gained 0.5% to 552.45 points, while most regional markets were up, except Spain’s IBEX, which dipped 0.1%.

EU trade chief Maros Sefcovic said progress has been made on a deal with the U.S., which could be finalized in days. Talks include measures to protect the EU auto industry, according to officials.

European mining stocks jumped 2.8%, and healthcare stocks rose 1.1%.

Meanwhile, Barry Callebaut shares dropped 7.2% after the Swiss chocolate maker lowered its sales forecast for the third time this year.

European investors are preparing for the key second-quarter earnings season, which will reveal how companies are handling trade volatility and how stable their stock prices are.

Analysts have been lowering 2025 earnings forecasts for 55 weeks straight, though the rate of cuts has slowed since May. Europe’s full-year earnings growth is now predicted at 3%, down from 8% earlier this year.

On the FX front, the U.S. dollar steadied on Thursday after pulling back from a two-week high. The , which tracks it against six major currencies, stayed flat at 97.416 after slipping 0.2% on Wednesday. It had hit a high of 97.837 earlier that day before losing steam.

The US dollar fell after U.S. Treasury yields dropped sharply on Wednesday, following strong demand at a auction. This eased concerns about the earlier “Sell America” trend, where Treasuries, the dollar, and stocks were sold off.

The rose 0.1% to 1.1733, and the edged up 0.1% to 1.3609. The dollar remained stable at 146.32 yen and 0.79420 .

Currency Power Balance

Currency Power Balance

Source: OANDA Labs

Looking at commodities, continue to hold the high ground. WTI, however, has failed to break above the 200-day MA and could be set for a short-term correction and may be worth monitoring.

has recovered its shine and has risen to trade comfortably above the $3300/oz handle. Technicals do hint at further upside as Gold has bounced from the Fibonacci golden pocket area overnight.

Economic Data Releases and Final Thoughts

Looking at the economic calendar, another quiet day today with US initial jobless claims is the only release which may have some impact on markets. We do also have a host of central bank policymakers speaking today from both the Fed and Bank of England.

Beyond that further developments on the trade deal front will likely drive market moves and sentiment for the rest of the day.Economic Calendar

MarketPulse Economic Calendar

Chart of the Day – DAX Index

From a technical standpoint, the has recorded a bullish close yesterday breaking out of a six-week range.

The close above the 24330 may be a precursor for further gains, however a lot of this will depend on how the trade deal talks play out.

There remains a probability of a retest of the 24330 handle before the next leg to the upside especially if the trade deal talks drag on.DAX Index-Daily Chart

Source: TradingView.com

Support

Resistance

Original Post

Most Popular

More from Author

US Dollar Holds Steady as Trump Threatens 50% Tariffs on Brazil

Trump announces fresh round of tariffs on Brazil and smaller nations But...

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study – Pfizer (NYSE:PFE)

Pfizer Inc. PFE and Astellas Pharma Inc. ALPMF ALPMY on Thursday...

Read Now

FDA Grants Complete Approval To Moderna’s COVID-19 Vaccine For Children As Young As 6 Months – Moderna (NASDAQ:MRNA)

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s MRNA supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.The company’s COVID-19 vaccine, mRNA-1273, was previously available...

US Dollar Holds Steady as Trump Threatens 50% Tariffs on Brazil

Trump announces fresh round of tariffs on Brazil and smaller nations But only mild risk aversion as Nvidia (NASDAQ:) drives equities higher, hits $4 trillion cap Fed minutes erase July cut bets as doves in the minority, dollar supported Bitcoin hits record high, comes just shy of $112,000 Trump Stuck in...

The Market Everyone Gave Up On Is Crushing Nasdaq 100 In 2025 – Global X MSCI Greece ETF (ARCA:GREK), Invesco QQQ Trust, Series 1...

Greece's 2010 collapse was so severe it leased islands, gutted public jobs and pensions, while some abroad even joked about selling the Acropolis to appease creditors.Fast forward 15 years, and the picture couldn't be more different.The Athens Stock Exchange has soared nearly 34% year-to-date, making Greece the...

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study – Pfizer (NYSE:PFE)

Pfizer Inc. PFE and Astellas Pharma Inc. ALPMF ALPMY on Thursday released topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating Xtandi (enzalutamide), in combination with leuprolide and as a monotherapy, in men with non-metastatic hormone-sensitive prostate cancer with biochemical recurrence...

The Powell-Trump Clash is Set to Escalate

Growth challenges are mounting while tariffs will lift inflation, but stagflation fears are wide of the mark. The Fed will likely delay rate cuts until the end of the year, despite escalating pressure from the president, but may move in larger steps when it does cutConsumer Caution...

Why Is AbbVie Stock Trading Higher On Thursday? – AstraZeneca (NASDAQ:AZN), AbbVie (NYSE:ABBV)

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. ABBV, on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases.“Multispecifics including trispecific antibodies represent...

Dynamic Hedging and FX Risk Analysis Within Tactical Asset Allocation Rules

Often, investors fully hedge their portfolios for currency risk. This can lead to significant drag in performance for currencies with negative carry. However, not hedging the foreign currency exposure can lead to significant drawdowns, especially for conservative investments. In this paper, we consider a conservative, global tactical...

German CPI Confirmed at 2.0%, Euro Drifting, FOMC Split Over Cuts

The euro continues to have a quiet week and is drifting for a third consecutive day. In the European session, is trading at 1.1730, up 0.09% on the day.German Inflation Dips to 2% as food, Energy Prices FallGerman inflation rose 2.0% y/y in June, in line...

Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble? – Klotho Neurosciences (NASDAQ:KLTO)

Shares of Klotho Neurosciences, Inc. KLTO have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday after announcing an FDA nod on its ALS treatment candidate. What's Driving The Rally: Klotho announced it has received...

Eurozone Economic Weakness Laid Bare as US Front-Loading Effects Wane

Eurozone data remains volatile amid trade war developments, but the underlying trend is still sluggish. Uncertainty is slowing domestic demand, which contributes to our expectation of a further rate cut from the European Central Bank in SeptemberEurozone Economy Shows Further Weakness in the Second QuarterThe eurozone economy...

SeaStar Medical’s QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka – Johnson & Johnson...

When it comes to unmet needs in the nephrology space, acute kidney injury remains a significant concern. That's particularly true regarding pediatric AKI – each year, about 4,000 children with AKI require continuous renal replacement therapy (RRT), with a mortality rate of approximately 51-58%. Many of those...

Why Are Biotech Stocks Ultragenyx And Mereo Facing A Sell-Off? – Ultragenyx Pharmaceutical (NASDAQ:RARE), Mereo BioPharma Group (NASDAQ:MREO)

Ultragenyx Pharmaceutical Inc. RARE and Mereo BioPharma Group plc MREO stocks are plunging on Thursday.What Happened?The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward...